These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tolerance develops to the antiallodynic effects of the peripherally acting opioid loperamide hydrochloride in nerve-injured rats. He SQ; Yang F; Perez FM; Xu Q; Shechter R; Cheong YK; Carteret AF; Dong X; Sweitzer SM; Raja SN; Guan Y Pain; 2013 Nov; 154(11):2477-2486. PubMed ID: 23880055 [TBL] [Abstract][Full Text] [Related]
3. Peripherally acting mu-opioid receptor agonist attenuates neuropathic pain in rats after L5 spinal nerve injury. Guan Y; Johanek LM; Hartke TV; Shim B; Tao YX; Ringkamp M; Meyer RA; Raja SN Pain; 2008 Aug; 138(2):318-329. PubMed ID: 18276075 [TBL] [Abstract][Full Text] [Related]
4. Mu-opioid and noradrenergic α(2)-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured rats. Bee LA; Bannister K; Rahman W; Dickenson AH Pain; 2011 Jan; 152(1):131-139. PubMed ID: 21187272 [TBL] [Abstract][Full Text] [Related]
5. Low doses of cyclic AMP-phosphodiesterase inhibitors rapidly evoke opioid receptor-mediated thermal hyperalgesia in naïve mice which is converted to prominent analgesia by cotreatment with ultra-low-dose naltrexone. Crain SM; Shen KF Brain Res; 2008 Sep; 1231():16-24. PubMed ID: 18656459 [TBL] [Abstract][Full Text] [Related]
6. Possible involvement of prolonging spinal µ-opioid receptor desensitization in the development of antihyperalgesic tolerance to µ-opioids under a neuropathic pain-like state. Narita M; Imai S; Nakamura A; Ozeki A; Asato M; Rahmadi M; Sudo Y; Hojo M; Uezono Y; Devi LA; Kuzumaki N; Suzuki T Addict Biol; 2013 Jul; 18(4):614-22. PubMed ID: 21812868 [TBL] [Abstract][Full Text] [Related]
7. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling. Wang HY; Friedman E; Olmstead MC; Burns LH Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657 [TBL] [Abstract][Full Text] [Related]
8. Intrathecal ultra-low dose naloxone enhances the antihyperalgesic effects of morphine and attenuates tumor necrosis factor-α and tumor necrosis factor-α receptor 1 expression in the dorsal horn of rats with partial sciatic nerve transection. Yang CP; Cherng CH; Wu CT; Huang HY; Tao PL; Lee SO; Wong CS Anesth Analg; 2013 Dec; 117(6):1493-502. PubMed ID: 24257399 [TBL] [Abstract][Full Text] [Related]
9. Depression of C fibre-evoked spinal field potentials by the spinal delta opioid receptor is enhanced in the spinal nerve ligation model of neuropathic pain: involvement of the mu-subtype. Buesa I; Urrutia A; Aira Z; Salgueiro M; Bilbao J; Mozas M; Aguilera L; Zimmermann M; Azkue JJ Neuropharmacology; 2008 Dec; 55(8):1376-82. PubMed ID: 18775732 [TBL] [Abstract][Full Text] [Related]
10. Naloxone's pentapeptide binding site on filamin A blocks Mu opioid receptor-Gs coupling and CREB activation of acute morphine. Wang HY; Burns LH PLoS One; 2009; 4(1):e4282. PubMed ID: 19172190 [TBL] [Abstract][Full Text] [Related]
11. Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord. Kao JH; Gao MJ; Yang PP; Law PY; Loh HH; Tao PL Br J Pharmacol; 2015 Jan; 172(2):630-41. PubMed ID: 24866991 [TBL] [Abstract][Full Text] [Related]
12. Electroacupuncture Enhances the Antiallodynic and Antihyperalgesic Effects of Milnacipran in Neuropathic Rats. Li C; Ji BU; Kim Y; Lee JE; Kim NK; Kim ST; Koo S Anesth Analg; 2016 May; 122(5):1654-62. PubMed ID: 26962713 [TBL] [Abstract][Full Text] [Related]
13. Adding ultralow-dose naltrexone to oxycodone enhances and prolongs analgesia: a randomized, controlled trial of Oxytrex. Chindalore VL; Craven RA; Yu KP; Butera PG; Burns LH; Friedmann N J Pain; 2005 Jun; 6(6):392-9. PubMed ID: 15943961 [TBL] [Abstract][Full Text] [Related]
14. Ultra-Low Doses of Naltrexone Enhance the Antiallodynic Effect of Pregabalin or Gabapentin in Neuropathic Rats. Pineda-Farias JB; Caram-Salas NL; Salinas-Abarca AB; Ocampo J; Granados-Soto V Drug Dev Res; 2017 Dec; 78(8):371-380. PubMed ID: 28868795 [TBL] [Abstract][Full Text] [Related]
15. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat. Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324 [TBL] [Abstract][Full Text] [Related]
16. Spinal administration of a delta opioid receptor agonist attenuates hyperalgesia and allodynia in a rat model of neuropathic pain. Holdridge SV; Cahill CM Eur J Pain; 2007 Aug; 11(6):685-93. PubMed ID: 17175187 [TBL] [Abstract][Full Text] [Related]
17. Loss of spinal mu-opioid receptor is associated with mechanical allodynia in a rat model of peripheral neuropathy. Back SK; Lee J; Hong SK; Na HS Pain; 2006 Jul; 123(1-2):117-26. PubMed ID: 16564625 [TBL] [Abstract][Full Text] [Related]
18. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats. Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929 [TBL] [Abstract][Full Text] [Related]
19. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice. Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654 [TBL] [Abstract][Full Text] [Related]
20. Oxytrex: an oxycodone and ultra-low-dose naltrexone formulation. Webster LR Expert Opin Investig Drugs; 2007 Aug; 16(8):1277-83. PubMed ID: 17685875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]